Top compounds associated with response to MYBL2


Feature Type Standardized
Nominal ANOVA
mRNA NSC-87877 GDSC1000 pan-cancer AAC -0.1 0.008
mRNA KIN001-270 GDSC1000 pan-cancer AAC 0.095 0.008
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.098 0.008
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.1 0.009
mRNA BRD-A86708339 CTRPv2 pan-cancer AAC 0.14 0.009
mRNA Pazopanib GDSC1000 pan-cancer AAC -0.095 0.009
mRNA paclitaxel CCLE pan-cancer AAC 0.12 0.009
mRNA ML050 CTRPv2 pan-cancer AAC 0.1 0.009
mRNA masitinib CTRPv2 pan-cancer AAC -0.1 0.009
mRNA SN-38 GDSC1000 pan-cancer AAC -0.091 0.01
Download CSV